HUTCHMED (China) (HCM) Long-Term Investments (2014 - 2026)
HUTCHMED (China) (HCM) posted quarterly Long-Term Investments of $11.0 million for Q2 2026, up 120.4% year-over-year from $5.0 million in Q2 2025, and up 688.84% quarter-over-quarter from $1.4 million in Q4 2025.
HUTCHMED (China) (HCM) Long-Term Investments (2014 - 2026) Analysis & Trends
HUTCHMED (China) (HCM) has reported Long-Term Investments for 13 consecutive years, with $11.0 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Long-Term Investments rose 120.4% year-over-year to $11.0 million; the TTM figure through Jun 2026 stood at $11.0 million (up 120.4% YoY), while the FY2025 annual figure was $33.8 million, down 1.13% from the prior year.
- Long-Term Investments grew to $11.0 million in Q2 2026 per HCM's latest filing, from $1.4 million in the prior quarter.
- Across five years, Long-Term Investments topped out at $6.2 billion in Q4 2023 and bottomed at $1.4 million in Q4 2025.
- Historically, Long-Term Investments has averaged $721.1 million across 5 years, with a median of $11.0 million in 2026.
- Annual changes were most pronounced in 2023 — Long-Term Investments surged 65591.08% — and 2024, when it sank 99.84%.
- HUTCHMED (China)'s Long-Term Investments stood at $9.4 million in 2022, then soared by 65591.08% to $6.2 billion in 2023, then tumbled by 99.84% to $10.0 million in 2024, then tumbled by 86.03% to $1.4 million in 2025, then surged by 688.84% to $11.0 million in 2026.
- Business Quant data shows HCM's Long-Term Investments at $11.0 million in Q2 2026, $1.4 million in Q4 2025, and $5.0 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 92.58 Mn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 63.23 Mn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 1.14 Bn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 149.10 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 60.00 Mn |
| 10 | HUTCHMED (China) | 2.18 Bn | 2.18 Bn | - | 11.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 11.02 Mn |
| Dec 31, 2025 | 1.40 Mn |
| Jun 30, 2025 | 5.00 Mn |
| Dec 31, 2024 | 10.00 Mn |
| Jun 30, 2024 | 137.04 Mn |
| Dec 31, 2023 | 6.20 Bn |
| Jun 30, 2023 | 37.74 Mn |
| Dec 31, 2022 | 9.43 Mn |
| Jun 30, 2022 | 82.54 Mn |
| Dec 31, 2021 | 9.82 Mn |
| Jun 30, 2021 | 66.47 Mn |
| Mar 31, 2021 | 133.82 Mn |
| Dec 31, 2020 | 197.76 Mn |
| Jun 30, 2020 | 90.37 Mn |
| Dec 31, 2019 | 178.10 Mn |
| Sep 30, 2019 | 145.34 Mn |
| Jun 30, 2019 | 78.59 Mn |
| Mar 31, 2019 | 158.93 Mn |
| Dec 31, 2018 | -8.00 Mn |
| Sep 30, 2018 | 73.65 Mn |